HF
ARMP icon

HRT Financial’s Armata Pharmaceuticals ARMP Stock Holding History

HRT Financial’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,595
Closed -$108K – 4141
2026
Q1 		$108K Buy
+10,595
New +$89.2K ﹤0.01% 3341
2023
Q3 		– Sell
-19,742
Closed -$22K – 2375
2023
Q2 		$22K Sell
19,742
-11,452
-37% -$16.6K ﹤0.01% 2086
2023
Q1 		$52K Sell
31,194
-11,083
-26% -$25.7K ﹤0.01% 2123
2022
Q4 		$52K Buy
+42,277
New +$110K ﹤0.01% 2115

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

HRT Financial's ARMP Position: Q2 2026 in Review

HRT Financial sold out of Armata Pharmaceuticals (ARMP) in Q2 2026, closing a stake of 10,595 shares — an estimated $108K sold.

HRT Financial first reported a position in ARMP in Q4 2022 and held it in 4 quarters. The position peaked at $108K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • HRT Financial reported no remaining Armata Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 10,595 Armata Pharmaceuticals shares in Q2 2026, an estimated $108K.
  • HRT Financial first reported a position in Armata Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • HRT Financial's Armata Pharmaceuticals position peaked at $108K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.